+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Branded Generics Market by Dosage Form (Injections, Liquids, Tablets & Capsules), Therapeutic Area (Anti-Infectives, Cardiovascular, Central Nervous System), Application, Distribution Channel - Global Forecast 2025-2030- Product Image
Branded Generics Market by Dosage Form (Injections, Liquids, Tablets & Capsules), Therapeutic Area (Anti-Infectives, Cardiovascular, Central Nervous System), Application, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Branded Generics Market by Dosage Form (Injections, Liquids, Tablets & Capsules), Therapeutic Area (Anti-Infectives, Cardiovascular, Central Nervous System), Application, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5896414
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The branded generics market is experiencing a period of accelerated evolution as healthcare systems worldwide prioritize cost efficiency, patient access, and robust therapeutic outcomes. This transformation positions branded generics as vital instruments for pharmaceutical companies and healthcare payers aiming to maximize value amid dynamic regulatory and commercial shifts.

Market Snapshot: Branded Generics Market Size and Growth

The Branded Generics Market grew from USD 494.29 billion in 2024 to USD 567.75 billion in 2025 and is projected to reach USD 1.12 trillion by 2030, reflecting a CAGR of 14.74%. Expanding demand is driven by pressures to contain costs, access affordable therapies, and respond to ongoing innovation, ensuring the sector’s continued importance for senior decision-makers in pharmaceuticals.

Scope & Segmentation

  • Dosage Forms: Injections (intramuscular, intravenous, subcutaneous), liquids (suspensions, syrups), tablets and capsules (extended release, immediate release), topicals (creams, gels, ointments).
  • Therapeutic Areas: Anti-infectives, cardiovascular conditions, central nervous system disorders, gastrointestinal treatments, pain management across non-opioid and opioid categories.
  • Application Channels: Human health and animal health, including both companion animals (cats, dogs) and livestock, supporting diversified market reach and tailored marketing tactics.
  • Distribution Platforms: Drug stores, hospital pharmacies, online pharmacies (websites and mobile apps), plus retail networks composed of chain and independent pharmacies.
  • Key Regions: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East, and Africa (including the UK, Germany, France, Russia, and key EMEA markets), and Asia-Pacific (China, India, Japan, Australia, South Korea, and emerging Southeast Asian economies).
  • Leading Market Participants: Teva Pharmaceutical Industries Ltd, Sandoz International GmbH, Fresenius Kabi AG, Viatris Inc, Sun Pharmaceutical Industries Ltd, Dr. Reddy's Laboratories Ltd, Lupin Ltd, Cipla Ltd, Aurobindo Pharma Ltd, and Glenmark Pharmaceuticals Ltd.

Key Takeaways for Senior Decision-Makers

  • Branded generics enable stakeholders to balance cost control with continuity in therapeutic quality, appealing to payers under increasing financial scrutiny.
  • Pharmaceutical companies are realigning product portfolios toward branded generics, leveraging innovative branding and strategic marketing to support market share and patient adherence.
  • Advanced analytics, digital health platforms, and smart packaging are being adopted to personalize patient engagement and increase loyalty in competitive segments.
  • Industry participants are addressing supply chain vulnerability by investing in regional production hubs, supporting resilience against trade disruptions and raw material shortages.
  • Strategic partnerships and public-private alliances are crucial in navigating complex local reimbursement frameworks and promoting expanded access across emerging and mature markets.

Primary Keyword: Branded Generics Market

Assessing Tariff Impact: U.S. Trade Policies Reshaping Supply Chains

Recent adjustments to United States tariff policies are directly impacting branded generic pharmaceutical supply chains and cost structures. Manufacturers are adapting by exploring near-shore production, renegotiating supplier agreements, and evaluating capital expenditure for domestic expansion. These changes reinforce the importance of long-term planning and collaboration with contract manufacturing organizations. Optimized sourcing strategies and alternative trade corridors have become essential to sustain competitiveness and ensure continued patient access.

Methodology & Data Sources

This report utilizes a comprehensive research framework combining secondary sources—such as industry literature, regulatory filings, and public database insights—with primary interviews involving senior executives, regulatory officials, and supply chain experts. Advanced analytical tools support segmentation, benchmarking, and scenario analysis, with findings validated through subject matter expert reviews and iterative feedback loops.

Why This Report Matters

  • Provides actionable insights for creating resilient portfolio and supply chain strategies tailored to market reality and regulatory climates.
  • Enables leadership teams to benchmark against peers and anticipate shifts in patient needs, distribution channels, and competitive dynamics.
  • Delivers practical guidance for responding to tariff changes, regulatory developments, and technological advances driving differentiation in the branded generics market.

Conclusion

The branded generics sector is redefining how the pharmaceutical industry addresses affordability, access, and innovation. Informed strategies built on robust market intelligence will enable companies to respond confidently in rapidly evolving commercial and regulatory environments.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Strategies for market access and reimbursement in emerging BRICS markets driving branded generics adoption
5.2. Impact of biosimilar competition on branded generics pricing and portfolio diversification in Europe
5.3. Digital marketing innovations driving patient engagement and brand loyalty in the branded generics sector
5.4. Role of local manufacturing partnerships in reducing supply chain risks for branded generics in Africa
5.5. Regulatory pathways and patent litigation trends shaping branded generics launches in the United States
5.6. Strategic alliances between branded generics producers and pharmacy chains to expand retail distribution networks
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Branded Generics Market, by Dosage Form
8.1. Introduction
8.2. Injections
8.2.1. Intramuscular
8.2.2. Intravenous
8.2.3. Subcutaneous
8.3. Liquids
8.3.1. Suspensions
8.3.2. Syrups
8.4. Tablets & Capsules
8.4.1. Extended Release
8.4.2. Immediate Release
8.5. Topicals
8.5.1. Creams
8.5.2. Gels
8.5.3. Ointments
9. Branded Generics Market, by Therapeutic Area
9.1. Introduction
9.2. Anti-Infectives
9.2.1. Antibiotics
9.2.2. Antifungals
9.2.3. Antivirals
9.3. Cardiovascular
9.3.1. Anti-Dyslipidemics
9.3.2. Anti-Hypertensives
9.4. Central Nervous System
9.4.1. Anti-Depressants
9.4.2. Anti-Epileptics
9.4.3. Anti-Psychotics
9.5. Gastrointestinal
9.5.1. Antacids
9.5.2. Laxatives
9.6. Pain Management
9.6.1. Non-Opioid Analgesics
9.6.2. Opioids
10. Branded Generics Market, by Application
10.1. Introduction
10.2. Animal Health
10.2.1. Companion Animals
10.2.1.1. Cats
10.2.1.2. Dogs
10.2.2. Livestock
10.3. Human Health
11. Branded Generics Market, by Distribution Channel
11.1. Introduction
11.2. Drug Stores
11.3. Hospital Pharmacies
11.4. Online Pharmacies
11.4.1. Mobile App Pharmacies
11.4.2. Website Pharmacies
11.5. Retail Pharmacies
11.5.1. Chain Pharmacies
11.5.2. Independent Pharmacies
12. Americas Branded Generics Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Branded Generics Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Branded Generics Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Teva Pharmaceutical Industries Ltd
15.3.2. Sandoz International GmbH
15.3.3. Fresenius Kabi AG
15.3.4. Viatris Inc
15.3.5. Sun Pharmaceutical Industries Ltd
15.3.6. Dr. Reddy's Laboratories Ltd
15.3.7. Lupin Ltd
15.3.8. Cipla Ltd
15.3.9. Aurobindo Pharma Ltd
15.3.10. Glenmark Pharmaceuticals Ltd
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BRANDED GENERICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BRANDED GENERICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BRANDED GENERICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BRANDED GENERICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BRANDED GENERICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BRANDED GENERICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BRANDED GENERICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BRANDED GENERICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BRANDED GENERICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BRANDED GENERICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BRANDED GENERICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BRANDED GENERICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BRANDED GENERICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BRANDED GENERICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. BRANDED GENERICS MARKET: RESEARCHAI
FIGURE 24. BRANDED GENERICS MARKET: RESEARCHSTATISTICS
FIGURE 25. BRANDED GENERICS MARKET: RESEARCHCONTACTS
FIGURE 26. BRANDED GENERICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BRANDED GENERICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BRANDED GENERICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BRANDED GENERICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BRANDED GENERICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BRANDED GENERICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BRANDED GENERICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BRANDED GENERICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BRANDED GENERICS MARKET SIZE, BY INJECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BRANDED GENERICS MARKET SIZE, BY INJECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BRANDED GENERICS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BRANDED GENERICS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BRANDED GENERICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BRANDED GENERICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BRANDED GENERICS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BRANDED GENERICS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BRANDED GENERICS MARKET SIZE, BY LIQUIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BRANDED GENERICS MARKET SIZE, BY LIQUIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BRANDED GENERICS MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BRANDED GENERICS MARKET SIZE, BY SUSPENSIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BRANDED GENERICS MARKET SIZE, BY SYRUPS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BRANDED GENERICS MARKET SIZE, BY SYRUPS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BRANDED GENERICS MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BRANDED GENERICS MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BRANDED GENERICS MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BRANDED GENERICS MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BRANDED GENERICS MARKET SIZE, BY TOPICALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BRANDED GENERICS MARKET SIZE, BY TOPICALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BRANDED GENERICS MARKET SIZE, BY CREAMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BRANDED GENERICS MARKET SIZE, BY CREAMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BRANDED GENERICS MARKET SIZE, BY GELS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BRANDED GENERICS MARKET SIZE, BY GELS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BRANDED GENERICS MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BRANDED GENERICS MARKET SIZE, BY OINTMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BRANDED GENERICS MARKET SIZE, BY TOPICALS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BRANDED GENERICS MARKET SIZE, BY TOPICALS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTIVIRALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-DYSLIPIDEMICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-DYSLIPIDEMICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-HYPERTENSIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-HYPERTENSIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-DEPRESSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-DEPRESSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-EPILEPTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-EPILEPTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-PSYCHOTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTI-PSYCHOTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTACIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANTACIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BRANDED GENERICS MARKET SIZE, BY LAXATIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BRANDED GENERICS MARKET SIZE, BY LAXATIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BRANDED GENERICS MARKET SIZE, BY NON-OPIOID ANALGESICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BRANDED GENERICS MARKET SIZE, BY NON-OPIOID ANALGESICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BRANDED GENERICS MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BRANDED GENERICS MARKET SIZE, BY OPIOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BRANDED GENERICS MARKET SIZE, BY CATS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BRANDED GENERICS MARKET SIZE, BY CATS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BRANDED GENERICS MARKET SIZE, BY DOGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BRANDED GENERICS MARKET SIZE, BY DOGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL BRANDED GENERICS MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL BRANDED GENERICS MARKET SIZE, BY LIVESTOCK, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL BRANDED GENERICS MARKET SIZE, BY HUMAN HEALTH, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL BRANDED GENERICS MARKET SIZE, BY HUMAN HEALTH, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL BRANDED GENERICS MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL BRANDED GENERICS MARKET SIZE, BY DRUG STORES, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL BRANDED GENERICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL BRANDED GENERICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL BRANDED GENERICS MARKET SIZE, BY MOBILE APP PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL BRANDED GENERICS MARKET SIZE, BY MOBILE APP PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL BRANDED GENERICS MARKET SIZE, BY WEBSITE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL BRANDED GENERICS MARKET SIZE, BY WEBSITE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL BRANDED GENERICS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL BRANDED GENERICS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL BRANDED GENERICS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL BRANDED GENERICS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 133. AMERICAS BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 134. AMERICAS BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 135. AMERICAS BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2018-2024 (USD MILLION)
TABLE 136. AMERICAS BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2025-2030 (USD MILLION)
TABLE 137. AMERICAS BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2018-2024 (USD MILLION)
TABLE 138. AMERICAS BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2025-2030 (USD MILLION)
TABLE 139. AMERICAS BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, 2018-2024 (USD MILLION)
TABLE 140. AMERICAS BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, 2025-2030 (USD MILLION)
TABLE 141. AMERICAS BRANDED GENERICS MARKET SIZE, BY TOPICALS, 2018-2024 (USD MILLION)
TABLE 142. AMERICAS BRANDED GENERICS MARKET SIZE, BY TOPICALS, 2025-2030 (USD MILLION)
TABLE 143. AMERICAS BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 144. AMERICAS BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 145. AMERICAS BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2024 (USD MILLION)
TABLE 146. AMERICAS BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, 2025-2030 (USD MILLION)
TABLE 147. AMERICAS BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 148. AMERICAS BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 149. AMERICAS BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 150. AMERICAS BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 151. AMERICAS BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
TABLE 152. AMERICAS BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS BRANDED GENERICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS BRANDED GENERICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 169. UNITED STATES BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 170. UNITED STATES BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 171. UNITED STATES BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2018-2024 (USD MILLION)
TABLE 172. UNITED STATES BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2025-2030 (USD MILLION)
TABLE 173. UNITED STATES BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2018-2024 (USD MILLION)
TABLE 174. UNITED STATES BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2025-2030 (USD MILLION)
TABLE 175. UNITED STATES BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, 2018-2024 (USD MILLION)
TABLE 176. UNITED STATES BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, 2025-2030 (USD MILLION)
TABLE 177. UNITED STATES BRANDED GENERICS MARKET SIZE, BY TOPICALS, 2018-2024 (USD MILLION)
TABLE 178. UNITED STATES BRANDED GENERICS MARKET SIZE, BY TOPICALS, 2025-2030 (USD MILLION)
TABLE 179. UNITED STATES BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 180. UNITED STATES BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 181. UNITED STATES BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2024 (USD MILLION)
TABLE 182. UNITED STATES BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, 2025-2030 (USD MILLION)
TABLE 183. UNITED STATES BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 184. UNITED STATES BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 185. UNITED STATES BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 186. UNITED STATES BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 187. UNITED STATES BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
TABLE 188. UNITED STATES BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, 2025-2030 (USD MILLION)
TABLE 189. UNITED STATES BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 190. UNITED STATES BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 191. UNITED STATES BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. UNITED STATES BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. UNITED STATES BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, 2018-2024 (USD MILLION)
TABLE 194. UNITED STATES BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES BRANDED GENERICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES BRANDED GENERICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 205. CANADA BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 206. CANADA BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 207. CANADA BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2018-2024 (USD MILLION)
TABLE 208. CANADA BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2025-2030 (USD MILLION)
TABLE 209. CANADA BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2018-2024 (USD MILLION)
TABLE 210. CANADA BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2025-2030 (USD MILLION)
TABLE 211. CANADA BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, 2018-2024 (USD MILLION)
TABLE 212. CANADA BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, 2025-2030 (USD MILLION)
TABLE 213. CANADA BRANDED GENERICS MARKET SIZE, BY TOPICALS, 2018-2024 (USD MILLION)
TABLE 214. CANADA BRANDED GENERICS MARKET SIZE, BY TOPICALS, 2025-2030 (USD MILLION)
TABLE 215. CANADA BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 216. CANADA BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 217. CANADA BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2024 (USD MILLION)
TABLE 218. CANADA BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, 2025-2030 (USD MILLION)
TABLE 219. CANADA BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 220. CANADA BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 221. CANADA BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 222. CANADA BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 223. CANADA BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
TABLE 224. CANADA BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, 2025-2030 (USD MILLION)
TABLE 225. CANADA BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 226. CANADA BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 227. CANADA BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 228. CANADA BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 229. CANADA BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, 2018-2024 (USD MILLION)
TABLE 230. CANADA BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, 2025-2030 (USD MILLION)
TABLE 231. CANADA BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 232. CANADA BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 233. CANADA BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. CANADA BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. CANADA BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 236. CANADA BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 237. CANADA BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 238. CANADA BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 239. MEXICO BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 240. MEXICO BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 241. MEXICO BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2018-2024 (USD MILLION)
TABLE 242. MEXICO BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2025-2030 (USD MILLION)
TABLE 243. MEXICO BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2018-2024 (USD MILLION)
TABLE 244. MEXICO BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2025-2030 (USD MILLION)
TABLE 245. MEXICO BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, 2018-2024 (USD MILLION)
TABLE 246. MEXICO BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, 2025-2030 (USD MILLION)
TABLE 247. MEXICO BRANDED GENERICS MARKET SIZE, BY TOPICALS, 2018-2024 (USD MILLION)
TABLE 248. MEXICO BRANDED GENERICS MARKET SIZE, BY TOPICALS, 2025-2030 (USD MILLION)
TABLE 249. MEXICO BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 250. MEXICO BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 251. MEXICO BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2024 (USD MILLION)
TABLE 252. MEXICO BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, 2025-2030 (USD MILLION)
TABLE 253. MEXICO BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 254. MEXICO BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 255. MEXICO BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 256. MEXICO BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 257. MEXICO BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
TABLE 258. MEXICO BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, 2025-2030 (USD MILLION)
TABLE 259. MEXICO BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 260. MEXICO BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 261. MEXICO BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. MEXICO BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. MEXICO BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, 2018-2024 (USD MILLION)
TABLE 264. MEXICO BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, 2025-2030 (USD MILLION)
TABLE 265. MEXICO BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 266. MEXICO BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 267. MEXICO BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. MEXICO BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. MEXICO BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 270. MEXICO BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 271. MEXICO BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 272. MEXICO BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 273. BRAZIL BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 274. BRAZIL BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 275. BRAZIL BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2018-2024 (USD MILLION)
TABLE 276. BRAZIL BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2025-2030 (USD MILLION)
TABLE 277. BRAZIL BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2018-2024 (USD MILLION)
TABLE 278. BRAZIL BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2025-2030 (USD MILLION)
TABLE 279. BRAZIL BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, 2018-2024 (USD MILLION)
TABLE 280. BRAZIL BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, 2025-2030 (USD MILLION)
TABLE 281. BRAZIL BRANDED GENERICS MARKET SIZE, BY TOPICALS, 2018-2024 (USD MILLION)
TABLE 282. BRAZIL BRANDED GENERICS MARKET SIZE, BY TOPICALS, 2025-2030 (USD MILLION)
TABLE 283. BRAZIL BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 284. BRAZIL BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 285. BRAZIL BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2024 (USD MILLION)
TABLE 286. BRAZIL BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, 2025-2030 (USD MILLION)
TABLE 287. BRAZIL BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 288. BRAZIL BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 289. BRAZIL BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 290. BRAZIL BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 291. BRAZIL BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
TABLE 292. BRAZIL BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, 2025-2030 (USD MILLION)
TABLE 293. BRAZIL BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 294. BRAZIL BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 295. BRAZIL BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 296. BRAZIL BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 297. BRAZIL BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, 2018-2024 (USD MILLION)
TABLE 298. BRAZIL BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, 2025-2030 (USD MILLION)
TABLE 299. BRAZIL BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 300. BRAZIL BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 301. BRAZIL BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. BRAZIL BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. BRAZIL BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 304. BRAZIL BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 305. BRAZIL BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 306. BRAZIL BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 307. ARGENTINA BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 308. ARGENTINA BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 309. ARGENTINA BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2018-2024 (USD MILLION)
TABLE 310. ARGENTINA BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2025-2030 (USD MILLION)
TABLE 311. ARGENTINA BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2018-2024 (USD MILLION)
TABLE 312. ARGENTINA BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2025-2030 (USD MILLION)
TABLE 313. ARGENTINA BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, 2018-2024 (USD MILLION)
TABLE 314. ARGENTINA BRANDED GENERICS MARKET SIZE, BY TABLETS & CAPSULES, 2025-2030 (USD MILLION)
TABLE 315. ARGENTINA BRANDED GENERICS MARKET SIZE, BY TOPICALS, 2018-2024 (USD MILLION)
TABLE 316. ARGENTINA BRANDED GENERICS MARKET SIZE, BY TOPICALS, 2025-2030 (USD MILLION)
TABLE 317. ARGENTINA BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 318. ARGENTINA BRANDED GENERICS MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 319. ARGENTINA BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, 2018-2024 (USD MILLION)
TABLE 320. ARGENTINA BRANDED GENERICS MARKET SIZE, BY ANTI-INFECTIVES, 2025-2030 (USD MILLION)
TABLE 321. ARGENTINA BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, 2018-2024 (USD MILLION)
TABLE 322. ARGENTINA BRANDED GENERICS MARKET SIZE, BY CARDIOVASCULAR, 2025-2030 (USD MILLION)
TABLE 323. ARGENTINA BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2018-2024 (USD MILLION)
TABLE 324. ARGENTINA BRANDED GENERICS MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, 2025-2030 (USD MILLION)
TABLE 325. ARGENTINA BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, 2018-2024 (USD MILLION)
TABLE 326. ARGENTINA BRANDED GENERICS MARKET SIZE, BY GASTROINTESTINAL, 2025-2030 (USD MILLION)
TABLE 327. ARGENTINA BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
TABLE 328. ARGENTINA BRANDED GENERICS MARKET SIZE, BY PAIN MANAGEMENT, 2025-2030 (USD MILLION)
TABLE 329. ARGENTINA BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 330. ARGENTINA BRANDED GENERICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 331. ARGENTINA BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, 2018-2024 (USD MILLION)
TABLE 332. ARGENTINA BRANDED GENERICS MARKET SIZE, BY ANIMAL HEALTH, 2025-2030 (USD MILLION)
TABLE 333. ARGENTINA BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, 2018-2024 (USD MILLION)
TABLE 334. ARGENTINA BRANDED GENERICS MARKET SIZE, BY COMPANION ANIMALS, 2025-2030 (USD MILLION)
TABLE 335. ARGENTINA BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 336. ARGENTINA BRANDED GENERICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 337. ARGENTINA BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 338. ARGENTINA BRANDED GENERICS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 339. ARGENTINA BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 340. ARGENTINA BRANDED GENERICS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 341. EUROPE, MIDDLE EAST & AFRICA BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 342. EUROPE, MIDDLE EAST & AFRICA BRANDED GENERICS MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 343. EUROPE, MIDDLE EAST & AFRICA BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2018-2024 (USD MILLION)
TABLE 344. EUROPE, MIDDLE EAST & AFRICA BRANDED GENERICS MARKET SIZE, BY INJECTIONS, 2025-2030 (USD MILLION)
TABLE 345. EUROPE, MIDDLE EAST & AFRICA BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2018-2024 (USD MILLION)
TABLE 346. EUROPE, MIDDLE EAST & AFRICA BRANDED GENERICS MARKET SIZE, BY LIQUIDS, 2025-2030 (US

Samples

Loading
LOADING...

Companies Mentioned

  • Teva Pharmaceutical Industries Ltd
  • Sandoz International GmbH
  • Fresenius Kabi AG
  • Viatris Inc
  • Sun Pharmaceutical Industries Ltd
  • Dr. Reddy's Laboratories Ltd
  • Lupin Ltd
  • Cipla Ltd
  • Aurobindo Pharma Ltd
  • Glenmark Pharmaceuticals Ltd

Table Information

Report AttributeDetails
No. of Pages181
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 567.75 Billion
Forecasted Market Value ( USD ) by 2030 $ 1120 Billion
Compound Annual Growth Rate14.7%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Benign Prostatic Hypertrophy Drugs Market by Drug Class (5-Alpha Reductase Inhibitors, Alpha Blockers, Combination Therapy), Generic Status (Branded, Generic), Distribution Channel, Dosage Form - Global Forecast 2025-2030 - Product Image

Benign Prostatic Hypertrophy Drugs Market by Drug Class (5-Alpha Reductase Inhibitors, Alpha Blockers, Combination Therapy), Generic Status (Branded, Generic), Distribution Channel, Dosage Form - Global Forecast 2025-2030

  • Report
  • 185 Pages
  • Global
From
Branded Generics - Global Strategic Business Report - Product Image

Branded Generics - Global Strategic Business Report

  • Report
  • 354 Pages
  • Global
From
Branded Generics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Branded Generics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 190 Pages
  • Global
From
Branded Generics: Market Share, and Growth Analysis by Product Type (Tablets, Capsules, Liquids), Application, End User, Technology - Product Image

Branded Generics: Market Share, and Growth Analysis by Product Type (Tablets, Capsules, Liquids), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Branded Generics Market Report 2025 - Product Image

Branded Generics Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Branded Generics Market

Branded generics are generic drugs that are marketed under a brand name. They are typically manufactured by a generic drug company, but are sold under a brand name owned by a pharmaceutical company. Branded generics are typically sold at a higher price than generic drugs, but are still much cheaper than the original brand-name drug. They are often used to increase the market share of a generic drug company, as well as to increase the visibility of a generic drug in the marketplace. Branded generics are becoming increasingly popular in the pharmaceutical industry, as they offer a cost-effective alternative to brand-name drugs. They are also used to increase the market share of generic drug companies, as well as to increase the visibility of generic drugs in the marketplace. Some companies in the branded generics market include Teva Pharmaceuticals, Mylan, Sandoz, and Dr. Reddy's Laboratories. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.